Do you want to link to this External Website and leave Amgen.eu?

YOU ARE NOW LEAVING THIS WEBSITE.

Amgen Europe takes no responsibility for, and exercises no control over, the organizations, views, or accuracy of the information contained on this server or site.

NEWS Media careers Amgen Worldwide
Amgen Worldwide

A biotechnology pioneer since 1980, Amgen has reached millions of patients around the world.

Resources

Amgen has created a number of websites to better serve you with specific questions.

Scientific sources

Amgen Biopharmaceutical company, a pioneer in biotechnology.

We deliver medicines and healthcare
solutions to patients and society.

an-investment-we-cant-ignore-home-page

An Investment We Can't Ignore: Reflections on the Changing EU Pharmaceutical Landscape

amgen-eu-banner

Investing in Health Today is an Investment in a Healthier Tomorrow

home-eu-phrma

Advocating for Innovation in Europe’s Legislative Framework

Together we can do anything

Unmet Medical Needs are the Drivers of Pharmaceutical Innovation

Report-image

Report: ‘Patients’ Perspectives as a Catalyst for Action to Improving Osteoporosis Care’ by Ghent University

Teaser image _experts

A Detailed Diagnosis: The Key to Transforming Lung Cancer Care

An interview with oncologist, PD Dr. med. Matthias Scheffler and President of LuCE, Dr. Anne-Marie Baird

flag-thumbnail

Feedback From Amgen: Revision of the EU General Pharmaceuticals Legislation

AmgenHistory_FeaturedNews_HomepageImage

Amgen Revolutionizing Science through the Decades

40 years of biotechnology

Our Perspectives

3/23/2020

Predict & Prevent: Now is the time to embrace the shift from reactive care to proactive, predictive and preventive care. 
Our Perspectives

Amgen's Dedication to Heart Disease and Osteoporosis

Amgen is dedicated to the fight against heart disease and osteoporosis and has now launched ProtectUrLife. The collective goal of this pan-European campaign is to empower the aging population to act on vital knowledge to help prevent life-alteringevents such as heart attack, stroke, and bone fracture.

Learn More

Psoriasis is a long-lasting disease, requiring continuous management. Amgen’s “Visible Psoriasis, Invisible Impact”, aims to help patients understand and discuss their psoriasis. The campaign provides information on maximising consultations between patients and physicians by ensuring patients are able to share the full impact of their disease, and physicians are able to engage and respond to all aspects of the disease, both visible and invisible.

Learn More

​

Searching for the Answers Within

At Amgen, we believe in a “biology first” approach. We use cutting-edge science and technology to study the subtlest biological mechanisms in search of therapies that will improve the lives of those who suffer from diseases. Amgen believes the cure for disease can be found inside each and every one of us.

 

​

The Six Domains of Psoriatic Arthritis

Psoriatic arthritis is a diverse disease, affecting each person differently. To educate patients and physicians on the six domains of psoriatic arthritis and its individualistic nature, Amgen developed the “Six Domains” campaign. This platform provides patients with the tools to understand their disease and communicate their disease burden to physicians. It is also a resource to inform physicians on the importance of tailoring treatment to individual patient needs.

Learn More

Amgen Inspires

Amgen was one of the first companies to discover the potential of modern biotechnology for developing high-value medicines for patients. Biologics, biologic medicines, have made a demonstrable difference in the lives of patients with serious illnesses.

Learn more about biotechnology

Career in Biopharmaceuticals at Amgen

Are you seeking a career where you can truly make a difference in the lives of others? Do you want to grow along with us? Then Amgen is the right place for you.

View our vacancies